PSMD2 and breast carcinoma: PSMD2 physically interacts with p21 and p27 and mediates their degradation via the ubiquitin-proteasome pathway by cooperating with the deubiquitinating enzyme USP14, subsequently promoting cell proliferation and facilitating cell cycle progression in breast cancer [59].